India · Delayed Price · Currency is INR Global Health Earnings Call Transcripts
Fiscal Year 2026
-
Q3 FY26 delivered 19% revenue growth and strong operational metrics, with Noida hospital ramping up as planned and mature/developing hospitals showing robust margins. ARPOB growth is expected to moderate, and CapEx will be lower next year as major investments are complete.
-
Q2 FY 2026 saw 15% YoY revenue growth, 21% PAT growth, and strong cash flows, driven by robust performance in both mature and developing hospitals. Noida Hospital commenced operations, and major expansion projects in Guwahati and Mumbai are underway. Talent retention remains strong, with industry-wide RPOP growth moderating.
-
Q1 FY 2026 saw record income and EBITDA, with 19% revenue and 50% PAT growth year-on-year, driven by higher patient volumes and operational efficiency. Expansion continues with new hospitals in Ranchi and Noida, and a strong cash position supports future growth and acquisitions.
Fiscal Year 2025
-
Strong year-over-year growth in revenue, EBITDA, and patient volumes, with robust expansion plans including new hospitals in Mumbai, Pitampura, and Guwahati. Margins remain healthy, and the company declared its first-ever dividend, while maintaining a strong cash position and focusing on quality and capacity expansion.
-
Q3 FY25 delivered double-digit revenue and profit growth, driven by higher patient volumes and strong performance in both mature and developing hospitals. Major expansion projects are on track, with significant bed additions and new facilities planned, while the company maintains a robust cash position and favorable cost ratios.